WellMedr publishes one figure for one compound and repeats it three times with the unit attached, which is more consistency than most sellers here manage. The second set of figures on the same page is the grey market's, printed to be compared against, and recording those as this seller's would be exactly backwards.
What WellMedr charges
NAD+: $99/mo — starting at; the page prints the same figure three times, once with a month marker and once in an answer that says the price includes the online consultation and is the same at every dose
WellMedr is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
One figure, printed three times, with the unit
The same figure appears in the page header, in a comparison table and in an answer to its own pricing question.
Two of the three carry a month marker, and the answer adds that the price is the same at every dose and includes the online consultation.
Repeating a figure consistently across three surfaces is a small thing that makes it much easier to trust.
This row records it as a monthly rate because the seller says so in words, not because the layout implied it.
The other figures on the page belong to the market
A comparison table on the same page sets this seller against unsupervised online sellers and prints a price range for those.
That range is lower than this seller's own figure, and it is labelled with a warning rather than an offer.
A parser taking the lowest figure on the page would publish the grey market's range as this seller's price.
The same table also uses the absence of third-party testing as a criticism of that market — which is a criticism, not a claim about this seller's own product.
What is priced here and what is not
One figure is published for the single compound named, repeated three times on one page with a month marker and an explicit statement that it does not change with dose.
On documentation the finding is more specific: not claimed for its own product; the page uses third-party testing as a criticism of the market it compares itself against.
One hundred and thirty-seven of the two hundred and ten sellers here publish a figure somewhere on their own site, and this is one of them.
The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.
The gaps, measured against the roster
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares one of the sixteen compounds this site tracks, which puts it with the twenty-nine single-compound sellers here — anything else in this comparison has to be bought somewhere else.
Who it's for
Readers who want one compound, one figure and the unit stated.
Buyers who want the consultation included in the published price.
Shoppers who want the operating company named.
Anyone comparing a flat-rate model against a dose-tiered one.
Who should look elsewhere
Readers who want more than one compound from a single seller.
Buyers who want the dispensing pharmacy named.
Anyone who needs a state footprint.
Shoppers looking for sermorelin, GHK-Cu, BPC-157 or anything beyond the one compound named.
Strengths
Prints the same figure three times with the unit, and says it does not change with dose
Names the company on the other side of the transaction rather than only a trading name
Publishes a figure on its own site with the unit recorded beside it
Answers the category question in plain language rather than in a disclaimer
Trade-offs
Offers a single tracked compound, so nothing else in this comparison can be bought here
Publishes no state list and names no dispensing pharmacy
Describes no lab work as included in what it charges
Describes no lab work as included in what it charges
How we verified this
Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Read every figure on the page in its own sentence and set aside the comparison range, which describes unsupervised sellers rather than this one.
Recorded the figure as monthly on the strength of the seller's own words rather than the layout, and noted its statement that the price does not change with dose.
Read the third-party-testing sentence as the criticism of another market that it is, rather than as a claim about this seller's product.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.
A provider to compare WellMedr against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Yes. The seller prints it with a month marker and separately answers its own pricing question by saying it is a monthly rate that includes the online consultation.
Does the price change with the dose?
The seller says it does not, and it names a dose range covered by the same figure.
What are the other figures on the page?
A range attributed to unsupervised online sellers, printed in a comparison table as a warning. They are not this seller's prices.
Does it claim third-party testing?
Not for its own product. The phrase appears as a criticism of the market it compares itself against.
Which states does it serve?
No list is published; the page says coverage is expanding and directs readers to check during the intake.
WellMedr is not a paid partner; this link may earn a commission if that changes. Full disclosure.